Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Impact of the V0034CR 01B emollient on atopic dermatitis symptoms in children
2008-003485-25Phase 4Completed
- Sponsor
- Pierre Fabre Laboratories
- Start
- Aug 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in atopic dermatitis (AD) comparing V0034CR 01B emollient with Placebo emollient (2 arms). Primary endpoint: Mean POEM score over 12 weeks. Started Aug 2008; status: completed.
02
Drugs
Dexeryl
03
Conditions
atopic dermatitis (AD)
Beyond the preview
Go deeper on 2008-003485-25.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-003485-25.